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Adequate antimicrobial therapy initiated as early as possible
following the onset of infection has been shown to positively
impact on an individual’s prognosis.1 As the epidemiology of
pathogens causing hospital-acquired infections is dynamic,
knowledge of local ecology data is of key importance when
making this assessment.2,3
In the latest issue of the International Journal of Infectious
Diseases we read with interest the article by Dr Baskaran and
co-workers in which the authors aimed to determine local
patterns and antibiotic susceptibilities of pathogens causing
bacteremia in patients who developed febrile neutropenia
after having received chemotherapy.4 However, we want to
comment on some specific aspects regarding themethodology
used and the conclusions formulated.
Firstly, patients with febrile neutropenia due to recent
chemotherapeutic treatment are commonly perceived as very
sick patients, and as such one might suppose that: (1) they
more frequently present either infectious or non-infectious
signs of systemic infection, and (2) consequently the threshold
for sampling blood for culture in this cohort should be lower as
compared to other general ward patients.5 Nevertheless, the
authors did not elucidatewhether a particular protocol and/or
procedure was available for performing blood cultures.
Secondly, 23.3% of all infective foci were reported to be
line-related infections.4 In our opinion this is an overestima-
tion of the true incidence in their setting, which can, at least
partly, be explained by the definition used. The authors
considered infection to be line-associated if there was ‘clin-
ical’ evidence of line infection or if the criteria for bacter-
emia were satisfied in the absence of other sites of infection.
With respect to the latter, which is bacteremia with uni-
dentifiable inciting focus, we think primary bacteremia
would be a more appropriate definition.6,7
Finally, as correctly stated by Dr Baskaran and co-workers,
surveillance may be another important issue for monitoring
rates of multiple-drug resistant organisms. Moreover, as
demonstrated in two studies by our group, Depuydt et al.
showed that based on general risk factors and knowledge of
the patient colonization status as assessed by regular sur-
veillance cultures, surveillance-assisted initiation of empiri-
cal antibiotics performed significantly better as compared to
strict empirical regimens proposed by our national guide-
lines.8—10 In doing this, the use of last-line and broad-spec-
trum antibiotics (e.g., fluoroquinolones, aminoglycosides,
and glycopeptides) could be substantially reduced, and prob-
ably also antibiotic-related costs.9,11 However, non-anti-
pseudomonal beta-lactams and carbapenems as empirical
regimen were prescribed more often, the latter only for
those patients identified to be colonized with Pseudomonas
aeruginosa. We would appreciate further elaboration of
these issues from the authors.
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